Cargando...
Terminal arbor degeneration (TAD): a novel lesion produced by the antineoplastic agent, paclitaxel
The anti-neoplastic agent, paclitaxel, causes a dose-limiting distal, symmetrical, sensory peripheral neuropathy that is often accompanied by a neuropathic pain syndrome. In a low-dose model of paclitaxel-evoked painful peripheral neuropathy in the rat, we have shown that the drug causes degeneratio...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3086946/ https://ncbi.nlm.nih.gov/pubmed/21395870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1460-9568.2011.07652.x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|